Genenta Science SpA ADR (GNTA)

Currency in USD
3.702
-0.158(-4.09%)
Closed·
GNTA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GNTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.7003.960
52 wk Range
2.7407.280
Key Statistics
Prev. Close
3.702
Open
3.72
Day's Range
3.7-3.96
52 wk Range
2.74-7.28
Volume
4.45K
Average Volume (3m)
12.64K
1-Year Change
-12.48%
Book Value / Share
0.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GNTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
24.608
Upside
+564.71%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Genenta Science SpA ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Genenta Science SpA ADR Company Profile

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy.

Compare GNTA to Peers and Sector

Metrics to compare
GNTA
Peers
Sector
Relationship
P/E Ratio
−6.6x−2.2x−0.5x
PEG Ratio
−0.280.030.00
Price/Book
4.7x1.3x2.6x
Price / LTM Sales
-8.7x3.2x
Upside (Analyst Target)
-98.2%42.0%
Fair Value Upside
Unlock−9.3%6.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 24.608
(+564.71% Upside)

Earnings

Latest Release
Mar 28, 2025
EPS / Forecast
-0.27 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GNTA Income Statement

People Also Watch

47.100
LDOF
-1.57%
90.55
TER
-0.65%
241.33
TSM
-0.58%
288.73
ELV
+0.96%
6.620
BBAI
-7.41%

FAQ

What Stock Exchange Does Genenta Science ADR Trade On?

Genenta Science ADR is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Genenta Science ADR?

The stock symbol for Genenta Science ADR is "GNTA."

What Is the Genenta Science ADR Market Cap?

As of today, Genenta Science ADR market cap is 67.71M.

What Is Genenta Science ADR's Earnings Per Share (TTM)?

The Genenta Science ADR EPS (TTM) is -0.49.

From a Technical Analysis Perspective, Is GNTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genenta Science ADR Stock Split?

Genenta Science ADR has split 0 times.

How Many Employees Does Genenta Science ADR Have?

Genenta Science ADR has 13 employees.

What is the current trading status of Genenta Science ADR (GNTA)?

As of 30 Jul 2025, Genenta Science ADR (GNTA) is trading at a price of 3.70, with a previous close of 3.70. The stock has fluctuated within a day range of 3.70 to 3.96, while its 52-week range spans from 2.74 to 7.28.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.